http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ME-P10608-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
filingDate 2004-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0ca940d7b162468f02dcec3cfae6efe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49426649cf9d5e8dd79f94492c849f43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59585f964279b476a1c847af2e23f5fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_421261415d3517821f3f95eeb819d9c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_022542a38e648692f2974161140a7e4e
publicationDate 2010-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ME-P10608-A
titleOfInvention APPLICATION OF PIRAZOL DERIVATIVES FOR OBTAINING MEDICINES USED FOR PREVENTION AND TREATMENT OF DISLIPIDEMIA AND DISEASES RELATED TO DISLIPIDEMIA AND / OR OBESITY
abstract The use of a compound that is a CB1 cannabinoid receptor antagonist and a pyrazole derivative, selected from rimonaban and N-piperidino-5- (4-bromophenyl) -1- (2,4-dichlorophenyl) -4-ethylpyrazole-3-carboxamide, alone or with some other active principle, for the preparation of medicaments useful in the prevention and treatment of dyslipidemias and diseases related to dyslipidemias and / or obesity, such as metabolic syndrome, cardiovascular risks and liver diseases.
priorityDate 2003-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409151871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9849616

Total number of triples: 36.